CAS: 425613-09-8
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
SJ000291942 REF: AN-AG01EO6LCAS: 425613-09-8 | 99% | 148.00 €~659.00 € | Fri 03 May 24 | |
SJ000291942 REF: TM-T4662CAS: 425613-09-8 | 99.07% | 45.00 €~582.00 € | Fri 10 May 24 | |
SJ000291942 REF: 3D-ASA61309CAS: 425613-09-8 | Min. 95% | To inquire | Fri 14 Jun 24 |
Ref: AN-AG01EO6L
5mg | 148.00 € | |
50mg | 174.00 € | |
100mg | 292.00 € | |
250mg | 659.00 € |
Estimated delivery in United States, on Friday 3 May 2024
SJ000291942
CAS:425613-09-8
SJ000291942 is an activator of the canonical bone morphogenetic proteins (BMP) signaling pathway.
Formula:
C16H15FN2O4
Purity:
99.07%
Color and Shape:
Solid
Molecular weight:
318.3
Ref: TM-T4662
2mg | 45.00 € | |
5mg | 66.00 € | |
10mg | 104.00 € | |
25mg | 227.00 € | |
50mg | 393.00 € | |
100mg | 582.00 € | |
1ml*10 (DMSO) | 73.00 € |
Estimated delivery in United States, on Friday 10 May 2024
SJ000291942
CAS:425613-09-8
SJ000291942 is a drug that inhibits the growth of cancer cells in the laboratory. It …
Formula:
C16H15FN2O4
Purity:
Min. 95%
Molecular weight:
318.3 g/mol
Ref: 3D-ASA61309
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Friday 14 Jun 2024